Oxford Academic Health Partners

What Oxford Academic Health Partners does

Oxford Academic Health Partners (OAHP) is a public-sector academic health partnership that unites Oxford's four anchor institutions — the University of Oxford (#1 globally for Medicine for 15 consecutive years), Oxford Brookes University (#1 in UK for nursing and midwifery), Oxford University Hospitals NHS Foundation Trust (13 hospitals) and Oxford Health NHS Foundation Trust — together with Health Innovation Oxford & Thames Valley to accelerate translational health research and innovation across Oxfordshire, the Thames Valley and the South East of England. The partnership operates the Oxford Joint Research Office (JRO), coordinates clinical research infrastructure, and convenes a research-enabled workforce of approximately 29,000 staff, supporting the recruitment of 41,000 patients into health research in a single year and the creation of 205 University of Oxford spinouts since 2011.

OAHP's technology portfolio is not built in-house but is facilitated through its network: it provides clinical validation sites, NHS adoption pathways and governance support for AI-powered health innovations developed by Oxford-affiliated spinouts. These include Brainomix's e-Stroke Suite (AI-enabled computer-vision decision support for stroke diagnosis, deployed across 78 NHS hospitals), Optellum's Virtual Nodule Clinic (AI-powered predictive analytics for early lung cancer diagnosis, FDA 510(k) cleared and CE-MDR/UKCA marked) and Ufonia's Dora (the first UKCA-marked conversational AI clinical assistant for automated post-operative patient follow-up). Distribution is via direct deployment through the partner NHS Trusts, regional expansion led by Health Innovation Oxford & Thames Valley across NHS England South East, and global commercialization through the spinouts.

The business model is non-commercial: OAHP functions as a partnership facilitator rather than a revenue-generating entity. It is funded through public research grants (notably £122m for two NIHR Biomedical Research Centres, £16.3m for the NIHR Applied Research Collaboration Thames Valley, £10m from GSK for an Experimental Medicine Collaboration) and through in-kind contributions from its anchor institutions. Pricing is not publicly disclosed and no commercial pricing models exist. The organisation is governed by an independent board chaired by Professor Sir Jonathan Montgomery (from September 2024, succeeding Professor Sir John Bell), with Professor Keith Channon as Director, Dr Harriet Teare as Chief Operating Officer (from September 2025), and Dr Catherine Lenihan leading JRO transformation from June 2026.

Name

Oxford Academic Health Partners

Legal name

Oxford Academic Health Partners

Website

https://oahp.org.uk

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Oxford Academic Health Partners is a public-sector academic health partnership that unites the University of Oxford, Oxford Brookes University, two NHS Trusts and Health Innovation Oxford & Thames Valley to accelerate translational research, clinical trials and the NHS adoption of Oxford spinout innovations across Oxfordshire and the Thames Valley.

Ownership category

akta.pro rank

Product category

Academic Health Partnership Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Global Health Institutes & Programs (EDAHAGAM), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN), Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships (HLAJAOAL)

Keywords

• Academic health partnership
• Clinical research collaboration
• Translational health research
• NHS university partnership
• Health innovation translation

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Partnership Collaboration: OAHP functions as a partnership organization that brings together NHS Trusts, universities, and health innovation networks. It does not operate as a commercial revenue-generating entity but rather facilitates research collaboration, infrastructure sharing, and innovation translation across partner organizations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Oxford Academic Health Partners (OAHP) is a partnership organisation that unites Oxford's academic and health organisations — the University of Oxford, Oxford Brookes University, Oxford University Hospitals NHS Foundation Trust, Oxford Health NHS Foundation Trust, and Health Innovation Oxford & Thames Valley — to accelerate research and innovation. It coordinates joint research infrastructure (notably the Oxford Joint Research Office), streamlines governance and clinical trial set-up, and supports a research-enabled workforce, enabling health innovations to be translated into clinical practice.

Product overview

Oxford Academic Health Partners is a partnership organization that coordinates research and innovation across Oxford's academic and NHS organizations rather than operating a traditional product business. Its technology portfolio includes AI-powered healthcare innovations developed by Oxford spinout companies that OAHP supports: Brainomix e-Stroke Suite (AI-powered stroke imaging analysis), Optellum Virtual Nodule Clinic (AI-powered lung cancer risk assessment), and Ufonia's Dora (conversational AI for patient follow-up). These are independent commercial products from Oxford-based companies that OAHP facilitates and supports through its partnership network.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 41,000 patients recruited into health research in Oxfordshire in a single year
• +4 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature3 records

Partnerships

22 partnerships are on record, tiered major, core and strategic.

• Université Paris CitémajorStrategic or Co-development Partner · 8 June 2026Part of UK-France alliance to accelerate research into major diseases including women's health, infectious diseases, and pandemic preparedness.
• Institut PasteurmajorStrategic or Co-development Partner · 8 June 2026Part of UK-France alliance for accelerating diagnosis, treatment, and prevention of major diseases across borders.
• Diamond Light SourcemajorStrategic or Co-development Partner · 8 June 2026Part of UK-France alliance providing synchrotron research capabilities for medical research collaboration.
• Synchrotron SOLEILmajorStrategic or Co-development Partner · 8 June 2026French synchrotron facility part of UK-France alliance for cross-border research acceleration.
• NIHR Applied Research Collaboration Thames ValleycoreStrategic or Co-development Partner · 1 April 202629 organisations across Thames Valley joined five-year research collaboration to develop and test practical solutions to improve health and care services.
• GSKmajorStrategic or Co-development Partner · 19 November 2025GSK invested £10 million over five years to establish Experimental Medicine Collaboration with University of Oxford for studying and treating immune mediated inflammatory diseases.
• Aarhus UniversitymajorStrategic or Co-development Partner · 21 August 2024Partnership to create Pioneer Centre for data-driven medical research, anchored at Aarhus University with hub sites at Oxford and University of Copenhagen.
• University of CopenhagenmajorStrategic or Co-development Partner · 21 August 2024International partnership for Pioneer Centre for medical data research, working with Aarhus University and University of Oxford.
• Apollo TherapeuticsmajorStrategic or Co-development Partner · 22 July 2024Portfolio biopharmaceutical company partnering with University of Oxford for drug discovery and development collaboration to translate biomedical research breakthroughs.
• Health Innovation Oxford & Thames ValleycoreStrategic or Co-development Partner · 1 October 2023Formerly Oxford AHSN, renamed Health Innovation Oxford and Thames Valley. Supports adoption of innovations across NHS and develops new care pathways. OAHP founding partner.
• GE HealthcarestrategicStrategic or Co-development Partner · 1 September 2022Strategic partnership with Optellum for expansion and commercial deployment of AI-powered lung cancer diagnosis technology.
• Johnson & Johnson (Lung Cancer Initiative)strategicStrategic or Co-development Partner · 1 August 2021Strategic collaboration with Optellum to apply AI-powered clinical decision support platform for lung cancer treatment transformation.
• University of OxfordcoreStrategic or Co-development PartnerWorld #1 ranked university for medicine, primary academic partner in OAHP partnership. Provides research expertise, academic leadership, and innovation capabilities across medicine and health sciences.
• Oxford University Hospitals NHS Foundation TrustcoreStrategic or Co-development PartnerNHS Trust with 13 hospitals providing clinical research facilities and patient access. Operates major hospitals including John Radcliffe, Churchill, and Nuffield Orthopaedic Centre.
• Oxford Health NHS Foundation TrustcoreStrategic or Co-development PartnerMental health NHS Trust partner providing clinical research infrastructure for mental health and community healthcare research.
• Oxford Brookes UniversitycoreStrategic or Co-development PartnerUK #1 ranked university for nursing & midwifery, contributing research expertise in allied health professions, nursing, and applied health research.
• BrainomixcoreTechnology or IntegrationOxford University spinout company developing e-Stroke AI platform. OAHP implemented the tool and continues to support implementation across the region.
• OptellumcoreTechnology or IntegrationOxford University spinout developing Virtual Nodule Clinic for early lung cancer diagnosis. Founded in 2017 by team from University of Oxford's Department of Engineering.
• UfoniacoreTechnology or IntegrationOxford-based SME developing Dora AI clinical assistant. OAHP facilitated access to organizations across Oxford to support technology validation and commercialization.
• NIHR Biomedical Research CentrecoreStrategic or Co-development PartnerOxford's two NIHR Biomedical Research Centres receive major funding (£122m) for health and care research across the partnership.
• Buckinghamshire Healthcare NHS TruststrategicImplementation/ SI/ Consulting PartnerFirst deployment and validation site for Ufonia's Dora AI clinical assistant, providing critical clinical evidence for the technology.
• Imperial College Healthcare TrustsstrategicImplementation/ SI/ Consulting PartnerNIHR-funded clinical trials completed for Ufonia's Dora AI clinical assistant technology.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Mayo Clinic: Large US integrated academic medical centre model combining research, education, and clinical care under a single brand with massive spinout and translational pipelines. Illustrative global benchmark for what an integrated academic health enterprise at scale looks like.

Emerging players

• Health Innovation Manchester: Manchester-based Academic Health Science Network focused on accelerating health innovation adoption into the NHS. Comparable AHSN function to Health Innovation Oxford & Thames Valley, which is an OAHP partner.

Regional players

• Northern Health Science Alliance: Collaboration of NHS trusts, universities, and Academic Health Science Networks across the North of England driving health research and innovation. Comparable partnership aggregator model with a different regional focus.
• Bristol Health Partners: UK Academic Health Partnership integrating the University of Bristol, UHBW NHS Trust, and other regional partners for translational health research. Same AHSC/AHP designation class as OAHP at smaller regional scale.

Direct peers

• King's Health Partners: Academic health science centre in London combining King's College London, Guy's and St Thomas', King's College Hospital, and South London and Maudsley NHS Foundation Trusts. Directly comparable integrated academic–NHS partnership model serving translational research.
• UCLPartners: Academic health science network and partnership covering North East and North Central London, anchored at UCL. Closest large-scale London analog to OAHP's Connect–Strengthen–Transform model with both research and NHS adoption mandates.
• Manchester Academic Health Science Centre: UK academic health partnership linking the University of Manchester, Manchester University NHS Foundation Trust, and other providers for translational health research. Same AHSC designation class as OAHP and comparable regional-scale translational remit.
• Imperial College Health Partners: London-based AHSP/ARC partnership connecting Imperial College London with NW London NHS providers. Comparable institutional partnership focused on clinical research infrastructure and innovation adoption.
• Cambridge University Health Partners: UK academic health partnership linking the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, and other regional partners to accelerate translational research. Most directly comparable UK peer to OAHP in structure and mission.

Others

• NIHR (National Institute for Health and Care Research): Primary funder of UK clinical research infrastructure, including OAHP's partner Biomedical Research Centres (£122m funding) and ARC Thames Valley. Acts as the upstream investor and policy sponsor that OAHP's partnerships ultimately depend on.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Ox_AHP
• LinkedInlinkedin.com/company/oxford-academic-health-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxford Academic Health Partners